The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 1.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 34% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (14 analysts) rates it strong buy, with a mean price target of $41. Insiders have been net sellers over the past quarter.
Life Time Group Holdings, Inc.
LTH · the NYSE · USD · Market cap $10.4B · 45,000 employees
Life Time Group Holdings, Inc., through its subsidiaries, provides health, fitness, and wellness experiences to a community of individual members in the United States and Canada.
FAIL · Does not pass the screenPrice as of 18 Nov 2026Daily close, not a live quote
Screened 2026-11-18 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price48.09 USD at the 18 Nov 2026 close
- Our value readFair vs our fair value, as of 18 Nov 2026
- Our regime readMarkup, as of 15 Nov 2026
- Ethical screenDoes not pass
- OptionsOpen interest leans heavily to calls (put/call 0.25)
- Last reviewed18 Nov 2026 (2 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $46.42 to $53.38, base estimate $46.42 (screen dated 2026-11-18).
- Trend Markup
- Insiders insiders sold, $300,951, latest filing 2026-10-30
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.25, read 2026-11-19
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
Life Time Group Holdings, Inc. holds its Markup at $48.09. The statistical read favours the sellers, held for 69 days.
| Phase | Markup |
| Quantitative state | The statistical read favours the sellers, held for 69 days |
| Price at the screen | $48.09 |
| Valuation | 25.15 trailing · 22.65 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 1.49 |
Five Screens: LTH's Results
FAIL. Debt ratio
| Test | Figure | Limit | Status |
|---|---|---|---|
| Business activity | Permissible | Permissible core business | Pass |
| Debt load | 51.88% | Below 33% | Fail |
| Interest-bearing cash | 0.00% | Below 33% | Pass |
| Receivables | 2.86% | Below 49% | Pass |
Definitions, sources and threshold rules: ticker values-screen methodology.
The Ethical ReadWhy It Falls Short, in Plain English
Life Time Group Holdings,'s business is in a permissible area, but its interest-bearing debt is about 52% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when LTH's ethical verdict changes
Today LTH does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Fair vs our fair value, as of 18 Nov 2026: it trades above our $46.42 fair value estimate, 14.20% revenue growth.
Model construction and limits: fair-value methodology.
Fair value range in USD, drawn from the 2026-11-18 screen. The gold marker is the market price at the same screen. The price runs 3.6% above the base estimate.
Third-party analyst targets: 15 covering, consensus Strong Buy. The average target sits +16% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere our models see it going: fair-value estimate $46.42, with a range of $46.42 to $53.38, dated to the 2026-11-18 screen.
How our estimate and third-party targets differ.
The Business, in Plain WordsPremium Gyms Trade Above Fair Value
Picture a packed fitness floor on a Monday evening. Members pay up for the experience while the company juggles new club builds and steady member growth. Life Time shows 12 percent revenue growth, 13 percent margins and a clean ethical pass, yet the current price sits 7 percent above our fair value.
That leaves little room for error. The forward multiple of 21.6 times already prices in continued expansion, and the strong buy analyst chorus does not change the simple arithmetic that the shares offer no margin of safety today.
Consumer leisure spending remains cyclical. Any slowdown in discretionary wallets or higher interest costs on expansion debt could quickly compress those margins and ROE. Analysis, not advice.
| Forward P/E | 22.7xpriced for continued growth |
| Trailing P/E | 25.1xa premium valuation |
| EPS, trailing | 1.85 |
| EPS, forward | 2.05 |
| Revenue growth | +14.2%steady growth |
| Profit margin | 12.7%thin but positive margins |
| Return on equity | 13.0%a solid return on shareholder capital |
| FCF yield | -3.81% |
| Debt to equity | 1.25a meaningful debt load worth watching |
| Current ratio | 0.73below 1: short-term bills exceed liquid assets |
| Beta | 1.49moves a little more than the market |
| Short interest, float | 0.06% |
| 52-week range | 24.46 - 48.61 |
| Market cap | $10.4B |
| Employees | 45,000 |
LTH-specific watchpoints · The things to watch: it already moves more than the market on an average day.
Metric definitions and interpretation rules: ticker-page methodology.
Every Entry, As Written
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 0.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 38% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (14 analysts) rates it strong buy, with a mean price target of $41. Insiders have been net sellers over the past quarter.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 13.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (14 analysts) rates it strong buy, with a mean price target of $41. Insiders have been net sellers over the past quarter.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (14 analysts) rates it strong buy, with a mean price target of $41. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (14 analysts) rates it strong buy, with a mean price target of $41. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (14 analysts) rates it strong buy, with a mean price target of $41. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (14 analysts) rates it strong buy, with a mean price target of $41. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 24% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (14 analysts) rates it strong buy, with a mean price target of $41. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 24% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (14 analysts) rates it strong buy, with a mean price target of $41. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 24% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (14 analysts) rates it strong buy, with a mean price target of $41. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Luxury Fitness Leader Life Time Flirts With Latest Buy Point In Tough Market Environment Yahoo Finance · 8d ago
- Why More Men Are Taking Pilates: Historically Dominated by Women, Life Time, the Nation's Largest Provider of Traditional Pilates, Sees Surging Male Demand Yahoo Finance · 10d ago
- Nearly 4,000 Runners Take On the 51st Annual Phoenix Half Marathon & 10K on Sun., Nov. 8 Yahoo Finance · 10d ago
- Life Time Is the Definitive Destination for Whole-Person Health Yahoo Finance · 16d ago
- Life Time and Dewitt Carolinas Break Ground on Life Time Living at The Exchange Raleigh Yahoo Finance · 18d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-30 | Weaver Erik | EVP, CFO | S - Sale | 6,713 | $300,951 |
| 2026-10-30 | Akradi Bahram | FOUNDER, CEO | S - Sale | 264,000 | $11,891,458 |
| 2026-10-12 | Weaver Erik | EVP, CFO | S - Sale | 5,787 | $230,149 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-10-23 | Gil Cisneros | Democrat | buy | 250K–500K |
| 2026-10-13 | Dave McCormick | Republican | sell | 250K–500K |
| 2026-10-13 | Dave McCormick | Republican | sell | 250K–500K |
| 2026-10-13 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-10-13 | Ro Khanna | Democrat | buy | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $32.34 | +3.5% | · | $1,035 | +3.5% |
| 2 months | $27.95 | +19.8% | · | $1,198 | +19.8% |
| 3 months | $25.74 | +30.1% | · | $1,301 | +30.1% |
| 6 months | $25.90 | +29.3% | · | $1,293 | +29.3% |
| 1 year | $27.78 | +20.5% | · | $1,205 | +20.5% |
| 2 years | $17.64 | +89.8% | · | $1,898 | +89.8% |
| 3 years | $20.10 | +66.6% | · | $1,666 | +66.6% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever LTH does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.